BioDuro and CTI Biotechnology Enter Strategic Partnership to Accelerate Preclinical Drug Development
IRVINE, California, April 28, 2026 – BioDuro, a trusted global Contract Research, Development and Manufacturing Organization (CRDMO), today announced a strategic partnership with CTI Biotechnology (Suzhou) Co., Ltd. ("CTI Biotechnology"), a leading provider of preclinical research services for innovative drug development. The collaboration will leverage the complementary strengths of both companies across critical stages of preclinical R&D to establish an integrated platform spanning from drug discovery to investigational new drug (IND) submission, providing global biotech and pharmaceutical clients with more efficient and flexible development solutions.